IL6 and hyperuricemia: On the other hand, in controls, the polymorphisms were associated with hypoalphalipoproteinemia, non-HDL cholesterol, apolipoprotein B, hyperuricemia, TNF-α, IL-6, IL-15, valvular calcification, and subclinical hypothyroidism.